PCOS 8 min read· 1 October 2026

Mounjaro for PCOS: Does Tirzepatide Help PCOS Weight Loss in India?

Mounjaro (tirzepatide) is not approved specifically for PCOS, but it targets the insulin resistance behind most PCOS weight gain, and early studies in women with PCOS are encouraging. PCOS-specific trials are still limited, it interacts with the contraceptive pill, and it must be stopped well before trying to conceive.

🩺

ALTRcare Medical Team

Clinical Editorial

Medically reviewed by Dr. (Major) Bhavesh TaleraMBBS (AFMC), MD (General Medicine), MRCP (UK), FRCP (Glasgow), PGDCCP · Reg. No. MP23180, Madhya Pradesh Medical CouncilHow we review our guides
A young woman writing in a journal on her bed in afternoon light

Mounjaro can help many women with PCOS lose weight, because it works directly on the insulin resistance that drives most PCOS weight gain. But it is approved in India for type 2 diabetes and chronic weight management, not for PCOS itself, and trials done specifically in women with PCOS are still few and small. Here is what is known, what is not, and the two practical rules (the pill and pregnancy) that every woman with PCOS needs to hear before starting.

Key takeaways

  • Insulin resistance sits underneath most PCOS. Tirzepatide lowers insulin resistance through weight loss and through its GIP action, which is why it is of real interest in PCOS.
  • PCOS-specific tirzepatide evidence is limited: one small, short randomised trial and real-world data so far. Larger trials are under way.
  • Oral contraceptive pills can be less reliable for 4 weeks after starting Mounjaro and after each dose increase. Use a backup method.
  • Mounjaro is not for pregnancy or while trying to conceive. It is stopped well before you try; your doctor advises how long.
  • For many women with PCOS and a lower BMI, generic semaglutide is a sensible, cheaper start. Tirzepatide suits higher BMI and marked insulin resistance.

Why insulin resistance is the key to PCOS weight

In most women with PCOS, the body needs more insulin than normal to handle the same meal. High insulin pushes the ovaries to make more androgens (male-type hormones), which disrupt ovulation and cause irregular periods, acne, facial hair and thinning scalp hair. High insulin also makes fat storage easier, especially around the waist. Dark velvety skin on the neck or underarms (acanthosis) is a visible sign of the same problem.

This is why modest weight loss often helps PCOS symptoms: losing even about 5% of body weight lowers insulin and, in many women, improves cycles. It is also why the standard advice (diet, exercise, metformin) sometimes stalls. When insulin resistance is marked, appetite and cravings fight every diet.

How Mounjaro works on that problem

Tirzepatide acts on two gut hormone receptors. Its GLP-1 action reduces appetite and slows stomach emptying. Its GIP action improves how fat and muscle respond to insulin. The result is two routes to lower insulin: the weight loss itself, and a direct improvement in insulin sensitivity. In the SURMOUNT-1 trial of adults with obesity (not a PCOS trial), average weight loss over 72 weeks was 15.0% at 5 mg, 19.5% at 10 mg and 20.9% at 15 mg, against 3.1% on placebo. Results vary from person to person.

What PCOS-specific evidence exists, honestly

This is where we need to be careful. Most of what we know about tirzepatide comes from trials in obesity and type 2 diabetes. Women with PCOS were included in those trials, but they were not studied as a separate group with PCOS outcomes such as ovulation or testosterone. The PCOS-specific evidence so far:

  • A small, short randomised trial in China (published in Diabetes, Obesity and Metabolism, 2026) compared tirzepatide plus metformin with metformin alone in women with PCOS and overweight or obesity. The combination produced greater reductions in weight and visceral fat, with better metabolic and reproductive markers. It was open-label and short-term.
  • A large UK real-world study (Journal of the Endocrine Society, August 2026) of women using tirzepatide through a digital weight service found that women who reported having PCOS lost about as much weight as women without it. PCOS was self-reported and the data is observational.
  • Dedicated trials are under way, including studies looking at ovarian function and menstrual regularity. Results are not yet available.

What this means for you

The weight-loss effect of tirzepatide looks similar in women with and without PCOS. What is not yet proven in large trials is whether it restores ovulation, lowers testosterone or improves fertility better than other options. Semaglutide currently has more PCOS-specific research. A good doctor will tell you this, not sell you a cure.

For a side-by-side of the two molecules in PCOS, including a decision guide by BMI and insulin levels, read semaglutide vs tirzepatide for PCOS. For the wider picture of GLP-1s and PCOS, see PCOS weight loss with GLP-1.

The contraceptive pill: read this before you start

Many women with PCOS take a combined oral contraceptive pill, either for contraception or to regulate cycles. Tirzepatide slows stomach emptying, and that can reduce how well the pill is absorbed. Oral contraceptives can be less reliable for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase. During those windows, use a backup method such as condoms, or talk to your gynaecologist about a non-oral method (an IUD, implant or similar).

This matters more in PCOS than people expect. As weight falls and insulin drops, some women with PCOS start ovulating again after months or years of irregular cycles, so pregnancy can happen sooner than you think. Semaglutide does not carry this oral contraceptive warning, which is one reason some women choose it.

Pregnancy and trying to conceive

Mounjaro is not used in pregnancy and should not be taken while you are trying to conceive. If a pregnancy is in your plans, tell the doctor at your first consultation. Tirzepatide stays in the body for some weeks after the last dose, so it is stopped well before you start trying; your doctor will tell you how long for your situation (UK regulator advice, for example, is to keep using contraception for about two months after stopping). If you find you are pregnant while on Mounjaro, stop the injections and contact your doctor straight away.

Many women use a GLP-1 to lose weight and improve cycles first, then stop and try. That can be a sound plan, as long as the timing is set with your doctor and gynaecologist rather than guessed.

PCOS and the weight will not move?

Take the free 2-minute assessment. A senior specialist reviews your reports on a free video call and tells you whether tirzepatide, semaglutide or neither fits your PCOS and your plans.

Who with PCOS should consider Mounjaro

Having PCOS does not by itself make you eligible. The doctor looks at your BMI, waist, reports and history in the same way as for anyone else (see what BMI qualifies for weight-loss medication), then at the PCOS-specific questions: the pill, pregnancy plans and budget over six months or more. Useful reports include fasting insulin, HbA1c, thyroid and a hormone profile; our blood tests guide explains what each one tells the doctor.

PCOS and tirzepatide: how the decision usually goes
Your situationWhat a doctor usually considers
Higher BMI, high fasting insulin, dark neck skin, weight stuck despite metforminTirzepatide is a strong option if the budget allows
Lower BMI, irregular cycles, budget mattersGeneric semaglutide first; more PCOS data, much lower cost
On the pill for contraception and wanting to stay on itSemaglutide, or tirzepatide with a backup method around each dose change
Planning pregnancy within a few monthsTiming matters more than the molecule; plan the stop date with your doctor and gynaecologist
Pregnant or breastfeedingNot suitable
PCOS and tirzepatide: how the decision usually goes · A general guide, not a prescription. The decision depends on your reports, history and goals.

Metformin is not the enemy here. Many women with PCOS stay on metformin alongside a GLP-1, and that decision stays with the doctor who prescribed it. ALTRcare doctors manage the weight-loss programme only; they do not change your other long-term medicines, such as thyroid or blood pressure tablets, which remain with your own doctor.

Who you will see at ALTRcare

Every consultation is with one of four senior specialists. Dr. Archana Rathi, diabetologist and ex-Registrar at Bombay Hospital, focuses on PCOS and women's health and sees many of our PCOS patients. Dr. Mujeeb Afzal (MD, DM Endocrinology) covers the hormonal side, and Dr. (Major) Bhavesh Talera (MD, MRCP (UK), FRCP, internal medicine) covers the gut, liver and heart side of GLP-1 care, with Dr. Snigdha Sehgal (MD Internal Medicine) alongside. All four are senior specialists.

The free online doctor consultation is a 15–20 minute Google Meet call; a health coach calls first to note your details, and nothing is paid to book. If tirzepatide suits you, the tirzepatide 3-month plan is ₹34,999 (₹11,666 a month), covering 2.5 mg, 5 mg and 7.5 mg, three doctor consultations timed to each dose step, a nutritionist and personalised Indian diet plan, WhatsApp support and cold-chain delivery, GST included. If semaglutide suits you better, that plan is ₹10,999 for 3 months. If the doctor says medication is not right for you, you are told plainly, and there is no sales team to call you back.

Talk to a doctor who sees PCOS every week

Book your free video consultation through the 2-minute assessment. Bring your latest reports if you have them (insulin, HbA1c, thyroid, hormones), and your plans around pregnancy.

Mounjaro® is a registered trademark of Eli Lilly and Company. Yurpeak® is marketed in India by Cipla. ALTRcare is not affiliated with either company.

Frequently asked questions

Is Mounjaro good for PCOS?

It can help many women with PCOS lose weight because it lowers insulin resistance, the main driver of PCOS weight gain. It is not approved specifically for PCOS, and large PCOS-specific trials are still limited, so a doctor should weigh it against options such as semaglutide and metformin.

Does Mounjaro help PCOS periods and fertility?

Weight loss often improves cycles in PCOS, and early tirzepatide studies are encouraging, but large trials showing restored ovulation or better fertility are not yet published. Mounjaro must be stopped well before trying to conceive.

Can I take Mounjaro with the contraceptive pill?

You can, but the pill can be less reliable for 4 weeks after starting Mounjaro and after each dose increase. Use a backup method such as condoms during those windows, or discuss a non-oral method with your gynaecologist.

Can I take Mounjaro and metformin together for PCOS?

Often yes. Many women with PCOS continue metformin alongside a GLP-1. Keep that decision with the doctor who prescribed your metformin, and tell the ALTRcare doctor everything you take.

How long before trying to get pregnant should I stop Mounjaro?

Your doctor will advise the exact timing for you. Tirzepatide stays in the body for weeks, so it is stopped well before trying; UK regulator guidance is to continue contraception for about two months after the last dose.

It was never about willpower.

PCOS runs on insulin resistance. Our physician looks at the whole picture and tells you honestly what will help. Two minutes, and a doctor reviews every one.

This article is for general educational purposes and is not a substitute for personalised medical advice. GLP-1 medications are prescription-only and not suitable for everyone. Always consult a qualified doctor before starting, changing, or stopping any treatment.

Keep reading